Vitamin pills increase mortality

Denmark - Vitamins A, E and beta carotene, taken singly or with other supplements, 'significantly increase mortality' according to a review study released by the Cochrane Hepato-Biliary Group* at Copenhagen University Hospital. Their study, published in the Journal of the American Medical Association (JAMA), did not find evidence that vitamin C could increase longevity, but did find that selenium tended to reduce the risk of death.

The Copenhagen researchers analysed 68 previous trials of the five antioxidant supplements, involving 232,606 participants, and say their findings contradict those of observational studies that claim antioxidants improve health. ‘Considering that 10-20% of the adult population (80-160 million people) in North America and Europe may consume the assessed supplements, the public health consequences may be substantial.’

The team reported that 47 ‘low-bias risk’ trials, with 180,938 participants, were ‘best quality’. Based on those low-bias studies, vitamin supplements were found to be associated with a 5% increased risk of mortality. Beta carotene was associated with a 7% risk, vitamin A with a 16% risk and vitamin E with a 4% risk. No increased mortality risk with vitamin C or selenium were seen.

* The Cochrane is an international network of experts who carry out systematic reviews of scientific evidence on health interventions.

08.03.2007

More on the subject:

Related articles

Photo

News • Research on proximity impacts

Health harm from wind turbines? Study clears the air

Sleep disturbances, anxiety, suicide – wind turbines have been linked to a long list of health problems. But a new analysis finds no adverse outcomes. The danger, researchers say, lies elsewhere.

Photo

News • Drug safety research

Under the influence: Which medicines affect driving most?

A more comprehensive system for drug safety evaluation: Researchers have developed a new tool to estimate the risk of using medicines while driving.

Photo

News • Importance of tumor location

Testosterone slows glioblastoma growth in men

New research reveals that testosterone slows glioblastoma growth—the opposite of the androgen’s effect on tumors outside the brain.

Subscribe to Newsletter